Mayo-led study: Drug reduces hot flashes, improves breast cancer survivor quality of life

Research led by oncologists Roberto Leon-Ferre, M.D. and Charles Loprinzi, M.D. of Mayo Clinic has found that the drug oxybutynin helps to reduce the frequency and intensity of hot flashes in women who are unable to take hormone replacement therapy, including breast cancer survivors. These findings were presented at the 2018 San Antonio Breast Cancer Symposium.

Go to Source

(Visited 1 times, 4 visits today)

Site Footer

Sliding Sidebar